Search Result "BRAF inhibitor PLX4032"
BRAF as a Target for Cancer Therapy
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11 Issue: 3 Year: 2011 Page: 285-295
Author(s): Rodrigo Dienstmann, Josep Tabernero
BRAF Inhibitor Therapy for Melanoma, Thyroid and Colorectal Cancers: Development of Resistance and Future Prospects
Journal: Current Cancer Drug Targets
Volume: 14 Issue: 2 Year: 2014 Page: 128-143
Author(s): Md Atiqur Rahman,Ali Salajegheh,Robert Anthony Smith,Alfred King-yin Lam
Therapeutic Strategies for Targeting BRAF in Human Cancer
Journal: Reviews on Recent Clinical Trials
Volume: 2 Issue: 2 Year: 2007 Page: 121-134
Author(s): Christine A. Pratilas, David B. Solit
Clinical Impact of the Detection of BRAF Mutations in Thyroid Pathology: Potential Usefulness as Diagnostic, Prognostic and Theragnostic Applications
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 1 Year: 2010 Page: 1839-1850
Author(s): Sandra Lassalle, Veronique Hofman, Marius Ilie, Catherine Butori, Alexandre Bozec, Jose Santini, Philippe Vielh, Paul Hofman
Small-Molecule Inhibitors of Raf for Treatment of Malignant Diseases
Ebook: Frontiers in Anti-Infective Drug Discovery
Volume: 1 Year: 2010
Author(s): Li Li, Shuhong Wu, Wei Guo, Bingliang Fang
Doi: 10.2174/978160805158811001010238
Dabrafenib in Melanoma
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 9 Year: 2018
Author(s): Meredith McKean,Rodabe N. Amaria
Doi: 10.2174/9781681087016118090004
Recent Clinical Advances in the Treatment of Cutaneous Melanoma
Journal: Clinical Cancer Drugs
Volume: 2 Issue: 1 Year: 2015 Page: 16-28
Author(s): Martin Greco,Maximiliano Mestroni,Maximo de la Vega,Gonzalo Recondo,Matias E. Valsecchi,Gonzalo Recondo,Enrique Diaz Canton
Recent Progress in Mutation-driven Therapy, Immunotherapy and Combination Therapy for the Treatment of Melanoma
Journal: Current Cancer Drug Targets
Volume: 17 Issue: 2 Year: 2017 Page: 137-157
Author(s): Hazem I. Assi,Rita E. Assi
Ipilimumab and Vemurafenib: Two Different Routes for Targeting Melanoma
Journal: Current Cancer Drug Targets
Volume: 13 Issue: 8 Year: 2013 Page: 879-894
Author(s): Ana Burgeiro,Faustino Mollinedo,Paulo J. Oliveira
Metabolic Features of Melanoma: A Gold Mine of New Therapeutic Targets?
Journal: Current Cancer Drug Targets
Volume: 14 Issue: 4 Year: 2014 Page: 357-370
Author(s): Philippe Marchetti,Pierre Guerreschi,Jerome Kluza,Laurent Mortier